Otros idiomas Respiri Limited

Acciones

Mercado cerrado - Australian S.E. Otros sitios de cotización 08:10:14 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
0,026 ^AUD	+13,04 %		-3,70 %	-13,33 %

05/06	Respiri recauda 1 millón de dólares australianos mediante una colocación adicional; las acciones bajan un 7	MT
09/05	Transcript : Respiri Limited - Special Call

Respiri Raises AU$1 Million via Additional Placement; Shares Down 7%	05/06
Respiri to Raise AU$1.6 Million via Placement	30/04
Respiri Partners with Hawaii Independent Physician Association for Remote Patient Monitoring Program; Shares Up 3%	29/04
Respiri Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02
Respiri Limited Announces Executive Changes	28/01
Respiri Signs Deal to Integrate Echo IQ’s Cardiovascular Technology to Remote Monitoring System; Shares Fall 4%	25/01
Respiri Limited Appoints Tom Takubo as Non-Executive Director	13/12
Respiri Limited Announces Resignation of Brian Leedman as Non-Executive Director	03/11
Respiri Limited Secures Two Additional Healthcare Provider Contract	29/09/23
Australian Bourse Halts Trading in Respiri’s Securities	14/09/23
Respiri Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Respiri Completes Access Manages Services Acquisition	14/08/23
Respiri Completes AU$3 Million Share Purchase Plan	08/08/23
Respiri Extends Closing Date of Share Purchase Plan	25/07/23
Respiri Signs Marketing Agreement for Wheezo Device with Fi-Med Management	10/07/23
Respiri Limited Appoints Brian Leedman as Non-Executive Director	23/05/23
Respiri Appoints Chief Commercial Officer for US Market	12/04/23
Respiri Limited Appoints William Sigsbee as Chief Commercial Officer for the US Market	12/04/23
L'agenda di domani	27/02/23
Respiri Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/02/23

No hay resultados para esta búsqueda